APA (7th ed.) Citation

Saw Yen Ow, Eugene A. Kapp, Vesna Tomasetig, Anton Zalewski, Jason Simmonds, Con Panousis, . . . Matthias Pelzing. (2023). HDX-MS study on garadacimab binding to activated FXII reveals potential binding interfaces through differential solvent exposure. Taylor & Francis Group.

Chicago Style (17th ed.) Citation

Saw Yen Ow, Eugene A. Kapp, Vesna Tomasetig, Anton Zalewski, Jason Simmonds, Con Panousis, Michael J. Wilson, Andrew D. Nash, and Matthias Pelzing. HDX-MS Study on Garadacimab Binding to Activated FXII Reveals Potential Binding Interfaces Through Differential Solvent Exposure. Taylor & Francis Group, 2023.

MLA (9th ed.) Citation

Saw Yen Ow, et al. HDX-MS Study on Garadacimab Binding to Activated FXII Reveals Potential Binding Interfaces Through Differential Solvent Exposure. Taylor & Francis Group, 2023.